Skip to main content
Skip to "About this site"

Table A.16.1

Warning View the most recent version.

Archived Content

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please "contact us" to request a format other than those available.

Table A.16.1
In-house research and development (R&D) expenditures related to bioproducts in Canada, by region, 2014 and 2015
Table summary
This table displays the results of In-house research and development (R&D) expenditures related to bioproducts in Canada. The information is grouped by Region (appearing as row headers), 2014 and 2015, calculated using $ thousands units of measure (appearing as column headers).
Region	2014	2015
Region	$ thousands
Canada
Total in-house R&D expenditures	121,611^{Table A.16.1 Note D}	112,132^{Table A.16.1 Note D}
In-house bioproduct-related R&D expenses	75,567^{Table A.16.1 Note D}	72,978^{Table A.16.1 Note D}
In-house biomass-related R&D expenses	26,050^{Note E: Use with caution}	18,209^{Table A.16.1 Note D}
Other in-house R&D expenses	19,993^{Table A.16.1 Note D}	20,945^{Table A.16.1 Note D}
Atlantic provinces	101,617	91,187
Total in-house R&D expenditures	2,883^{Note E: Use with caution}	1,460^{Note E: Use with caution}
In-house bioproduct-related R&D expenses	2,810^{Note E: Use with caution}	1,399^{Note E: Use with caution}
In-house biomass-related R&D expenses	40^{Note E: Use with caution}	36^{Note E: Use with caution}
Other in-house R&D expenses	34^{Note E: Use with caution}	25^{Note E: Use with caution}
Quebec
Total in-house R&D expenditures	26,401^{Table A.16.1 Note D}	29,648^{Table A.16.1 Note D}
In-house bioproduct-related R&D expenses	12,842^{Note E: Use with caution}	17,761^{Note E: Use with caution}
In-house biomass-related R&D expenses	6,607^{Note E: Use with caution}	5,257^{Note E: Use with caution}
Other in-house R&D expenses	6,952^{Note E: Use with caution}	6,630^{Note E: Use with caution}
Ontario
Total in-house R&D expenditures	61,293^{Note E: Use with caution}	60,113^{Note E: Use with caution}
In-house bioproduct-related R&D expenses	48,635^{Note E: Use with caution}	45,691^{Note E: Use with caution}
In-house biomass-related R&D expenses	6,053^{Note E: Use with caution}	6,523^{Note E: Use with caution}
Other in-house R&D expenses	6,606^{Note E: Use with caution}	7,898^{Note E: Use with caution}
Prairies
Total in-house R&D expenditures	3,910^{Note E: Use with caution}	5,557^{Note E: Use with caution}
In-house bioproduct-related R&D expenses	Note x: suppressed to meet the confidentiality requirements of the Statistics Act	3,502^{Note E: Use with caution}
In-house biomass-related R&D expenses	1,014^{Note E: Use with caution}	1,429^{Note E: Use with caution}
Other in-house R&D expenses	Note x: suppressed to meet the confidentiality requirements of the Statistics Act	626^{Note E: Use with caution}
British Columbia
Total in-house R&D expenditures	27,123^{Note E: Use with caution}	15,355^{Note E: Use with caution}
In-house bioproduct-related R&D expenses	Note x: suppressed to meet the confidentiality requirements of the Statistics Act	4,625^{Table A.16.1 Note D}
In-house biomass-related R&D expenses	12,337^{Note E: Use with caution}	4,964^{Note E: Use with caution}
Other in-house R&D expenses	Note x: suppressed to meet the confidentiality requirements of the Statistics Act	5,766^{Note E: Use with caution}
x suppressed to meet the confidentiality requirements of the Statistics Act ^E use with caution Note: Coefficient of variation (CV) threshold Note D [ 0.150 < CV ≤ 0.250 ] Return to note D referrer Preliminary estimates, subject to change. Due to rounding, components may not add to totals. Coefficient of variation (CV) and standard error (SE) are used as quality indicators. Source: Statistics Canada, Bioproducts production and development survey 2015.

Date modified:: 2017-12-22